ARNI (Arno Therapeutics) Total Liabilities: $8.07 Mil (As of Sep. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Arno Therapeutics Total Liabilities?

Arno Therapeutics ARNI Total Liabilities is $8.07 Mil as of Sep. 2016.

Arno Therapeutics's Total Liabilities for the quarter that ended in Sep. 2016 was $8.07 Mil.

Arno Therapeutics's quarterly Total Liabilities declined from Mar. 2016 ($6.95 Mil) to Jun. 2016 ($6.32 Mil) but then increased from Jun. 2016 ($6.32 Mil) to Sep. 2016 ($8.07 Mil).

Arno Therapeutics's annual Total Liabilities declined from Dec. 2013 ($39.77 Mil) to Dec. 2014 ($8.84 Mil) but then increased from Dec. 2014 ($8.84 Mil) to Dec. 2015 ($8.99 Mil).

Arno Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Arno Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arno Therapeutics Total Liabilities Chart

Arno Therapeutics Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.67 25.16 39.77 8.84 8.99

Arno Therapeutics Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.65 8.99 6.95 6.32 8.07

Arno Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Arno Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2015 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.231+(0.004+4.75
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=8.99

Total Liabilities=Total Assets (A: Dec. 2015 )-Total Equity (A: Dec. 2015 )
=0.361--8.624
=8.99

Arno Therapeutics's Total Liabilities for the quarter that ended in Sep. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.527+(0.001+6.542
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=8.07

Total Liabilities=Total Assets (Q: Sep. 2016 )-Total Equity (Q: Sep. 2016 )
=2.356--5.714
=8.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $8.07 Mil mean?
Arno Therapeutics (ARNI) has a Total Liabilities of $8.07 Mil as of Sep. 2016. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Arno Therapeutics and its competitors.
Is Arno Therapeutics' Total Liabilities too high?
Arno Therapeutics' current Total Liabilities is $8.07 Mil.
How does Arno Therapeutics' Total Liabilities compare to PLPL and BTHE?
Arno Therapeutics' Total Liabilities of $8.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Arno Therapeutics and its competitors. Arno Therapeutics's current Total Liabilities is $8.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arno Therapeutics stock overvalued right now?
Arno Therapeutics (ARNI) has a current Total Liabilities of $8.07 Mil. The current Total Liabilities is $8.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Arno Therapeutics (ARNI), the current Total Liabilities is $8.07 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arno Therapeutics Business Description

Address 200 Route 31 North, Suite 104, Flemington, NJ, USA, 08822
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage product under the following name: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate and breast cancer indications, AR-42 is provided for hematological malignancies and solid tumors indications and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.